Xueqin Bai

Xueqin Bai

Auto-generated profile, based on publicly available information

Xueqin Bai

Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2022 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
XSXiaoli Si
Xiaoli Si
TGTao Guo
Tao Guo
ZWZhiyun Wang
Zhiyun Wang
YFYi Fang
Yi Fang
LGLuyan Gu
Luyan Gu
BZBaorong Zhang
Baorong Zhang
Alpha-synucleinopathy is postulated to be central to both idiopathic rapid eye movement sleep behaviour disorder (iRBD) and Parkinson’s disease (PD). Growing evidence suggests an association between the diminished clearance of α-synuclein and glymphatic system dysfunction. However, evidence accumulating primarily based on clinical data to support glymphatic system dysfunction in patients with iRBD and PD is currently insufficient. This study aimed to use diffusion tensor image analysis along the perivascular space (DTI-ALPS) to evaluate glymphatic system activity and its relationship to clinical scores of disease severity in patients with possible iRBD (piRBDs) and those with PD. Further, we validated the correlation between the ALPS index and the prognosis of PD longitudinally. Overall, 168 patients with PD, 119 piRBDs, and 129 healthy controls were enroled. Among them, 50 patients with PD had been longitudinally reexamined. Patients with PD exhibited a lower ALPS index than those with piRBDs (P = 0.036), and both patient groups showed a lower ALPS index than healthy controls (P < 0.001 andP = 0.001). The ALPS index and elevated disease severity were negatively correlated in the piRBD and PD subgroups. Moreover, the ALPS index was correlated with cognitive decline in patients with PD in the longitudinal analyses. In conclusion, DTI-ALPS provided neuroimaging evidence of glymphatic system dysfunction in piRBDs and patients with PD; however, the potential of assessing the pathological progress of α-synucleinopathies as an indicator is worth verifying. Further development of imaging methods for glymphatic system function is also warranted.

13 July 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
CZCheng Zhou
Cheng Zhou
LWLinbo Wang
Linbo Wang
CWCheng Wei
Cheng Wei
JLJinChao Lv
JinChao Lv
XGXiaojun Guan
Xiaojun Guan
MZMinming Zhang
Minming Zhang
Increasing evidence suggests that Parkinson’s disease (PD) exhibits disparate spatial and temporal patterns of progression. Here we used a machine-learning technique—Subtype and Stage Inference (SuStaIn) — to uncover PD subtypes with distinct trajectories of clinical and neurodegeneration events. We enrolled 228 PD patients and 119 healthy controls with comprehensive assessments of olfactory, autonomic, cognitive, sleep, and emotional function. The integrity of substantia nigra (SN), locus coeruleus (LC), amygdala, hippocampus, entorhinal cortex, and basal forebrain were assessed using diffusion and neuromelanin-sensitive MRI. SuStaIn model with above clinical and neuroimaging variables as input was conducted to identify PD subtypes. An independent dataset consisting of 153 PD patients and 67 healthy controls was utilized to validate our findings. We identified two distinct PD subtypes: subtype 1 with rapid eye movement sleep behavior disorder (RBD), autonomic dysfunction, and degeneration of the SN and LC as early manifestations, and cognitive impairment and limbic degeneration as advanced manifestations, while subtype 2 with hyposmia, cognitive impairment, and limbic degeneration as early manifestations, followed later by RBD and degeneration of the LC in advanced disease. Similar subtypes were shown in the validation dataset. Moreover, we found that subtype 1 had weaker levodopa response, more GBA mutations, and poorer prognosis than subtype 2. These findings provide new insights into the underlying disease biology and might be useful for personalized treatment for patients based on their subtype.

9 November 2022 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
XBXueqin Bai
Xueqin Bai
TGTao Guo
Tao Guo
JCJingwen Chen
Jingwen Chen
XGXiaojun Guan
Xiaojun Guan
CZCheng Zhou
Cheng Zhou
MZMinming Zhang
Minming Zhang
This study aimed to investigate the cortical microstructural/macrostructural degenerative patterns in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI). Overall, 38 PD patients with normal cognition (PD-NC), 38 PD-MCI, and 32 healthy controls (HC) were included. PD-MCI was diagnosed according to the MDS Task Force level II criteria. Cortical microstructural alterations were evaluated with Neurite Orientation Dispersion and Density Imaging. Cortical thickness analyses were derived from T1-weighted imaging using the FreeSurfer software. For cortical microstructural analyses, compared with HC, PD-NC showed lower orientation dispersion index (ODI) in bilateral cingulate and paracingulate gyri, supplementary motor area, right paracentral lobule, and precuneus (PFWE < 0.05); while PD-MCI showed lower ODI in widespread regions covering bilateral frontal, parietal, occipital, and right temporal areas and lower neurite density index in left frontal area, left cingulate, and paracingulate gyri (PFWE < 0.05). Furthermore, compared with PD-NC, PD-MCI showed reduced ODI in right frontal area and bilateral caudate nuclei (voxelP < 0.01 and cluster >100 voxels) and the ODI values were associated with the Montreal Cognitive Assessment scores (r = 0.440,P < 0.001) and the memory performance (r = 0.333,P = 0.004) in the PD patients. However, for cortical thickness analyses, there was no difference in the between-group comparisons. In conclusion, cortical microstructural alterations may precede macrostructural changes in PD-MCI. This study provides insightful evidence for the degenerative patterns in PD-MCI and contributes to our understanding of the latent biological basis of cortical neurite changes for early cognitive impairment in PD.

23 August 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
XBX. Bai
X. Bai
PLP. Lv
P. Lv
KLK. Liu
K. Liu
QLQ. Li
Q. Li
JDJing Ding
Jing Ding
JLJiang Lin
Jiang Lin
BACKGROUND AND PURPOSE: 3D high-resolution vessel wall imaging is increasingly used for intracranial arterial diseases. This study compared the diagnostic performance of black-blood luminal angiography derived from 3D vessel wall imaging with source images of vessel wall imaging and TOF-MRA in detecting middle cerebral artery stenosis. MATERIALS AND METHODS: Sixty-two patients with suspected MCA atherosclerosis underwent TOF-MRA, vessel wall imaging, and CTA. Intracranial black-blood luminal angiography was created from source images of vessel wall imaging using minimum intensity projection. The degree and length of MCA stenosis were measured on source images of vessel wall imaging, TOF-MRA, and black-blood luminal angiography and compared using CTA as a reference standard. RESULTS: The image quality of black-blood luminal angiography was diagnostic in most patients. The intra- and interobserver agreement for both stenosis degree and length measurements was excellent for black-blood luminal angiography. It was comparable with that of source images of vessel wall imaging in grading stenosis. Compared with TOF-MRA, black-blood luminal angiography showed significantly higher sensitivity for the detection of severe stenosis (89.3% versus 64.3%, P = .039) and higher specificity for the detection of occlusion (95.4% versus 84.6%, P = .039). Lesion length estimated on source images of vessel wall imaging was significantly greater than that measured by CTA and black-blood luminal angiography (P < .001 and P = .010). CONCLUSIONS: Black-blood luminal angiography is better than TOF-MRA in detecting severe stenosis and occlusion of the MCA. Compared with source images of vessel wall imaging, it is more accurate in evaluating stenosis length. Black-blood luminal angiography can be produced as a derivative from vessel wall imaging and implemented as an adjunct to vessel wall imaging and TOF-MRA without extra acquisition time.

10 November 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
YCYi-Qi Chen
Yi-Qi Chen
TYTao Yu
Tao Yu
ZSZheng-Qi Song
Zheng-Qi Song
QLQi-Chen Lu
Qi-Chen Lu
MJMorgan Jones
Morgan Jones
XBXue-Qin Bai
Xue-Qin Bai
Background: The last 30 years witnessed significant changes in motor neuron disease (MND) epidemiology. Our study aims to explore the trends and inequality of MND, and predict future changes to 2046. Methods: We used Global Burden of Disease (GBD) 2021 data and methodologies (including trends, decomposition, inequality, frontier, and prediction) to describe the disease burden of MND of incidence, prevalence, deaths, and disability-adjusted life-years (DALYs). Results: The case number of incidence, prevalence, deaths and DALYs illustrated an upward trend, however, the age-standardized rate (ASR) for these metrics remained stable. There is substantial variability in MND burden across regions and countries, with higher ASR observed in high sociodemographic index (SDI) regions, particularly the United States, Finland, and the United Kingdom. Gender and age differences also contribute to the disease burden, with males and older populations exhibiting higher incidence rates. The age-period-cohort analysis revealed distinct temporal trends of DALYs across age, period, and birth cohort. Decomposition analysis revealed population aging and growth are critical drivers of the increasing burden. Additionally, the cross-country inequality analysis indicates widening disparities in MND burden, particularly in high SDI regions, from 1990 to 2021. Forecasts for 2046 suggest that while the number of deaths and DALYs may decrease, the incidence and prevalence of MND are expected to continue rising. The frontier analysis further reveals significant differences in performance across countries, with certain high-SDI countries like Sweden and the United Kingdom underperform, indicating that socioeconomic advancements may not always translate into lower disease burden. Conclusions: The findings from this study underscore the need for more targeted interventions, better diagnostic practices, and international collaboration to address the growing global burden of MND. These insights offer a significant contribution to understanding the trends and regional disparities associated with MND, aiding in the development of global health strategies and public health policies to mitigate this burden.

14 March 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YCYi-Qi Chen
Yi-Qi Chen
ZCZhen-Ya Chen
Zhen-Ya Chen
ZSZheng-Qi Song
Zheng-Qi Song
HLHai-Bo Liang
Hai-Bo Liang
YLYi-Jun Li
Yi-Jun Li
XBXue-Qin Bai
Xue-Qin Bai
Background: Spinal diseases and their associated symptoms are prevalent across all age groups, and their incidence severely affects countless individuals’ quality of life. The role of daily habits in the progression of these diseases is increasingly emphasized in research. Moreover, there are reports suggesting associations between dietary factors and the onset of spinal diseases. However, the exact causal relationship between dietary factors and spinal diseases has not been fully elucidated.Methods: We obtained GWAS data on 16 dietary intake and 187 dietary likings from the UK Biobank, and GWAS data on 23 types of spinal disorders from FinnGen R10. The analysis of causal effects was conducted using the Inverse Variance Weighted (IVW) test, and to ensure robustness, MR-Egger, Weighted median, and Bayesian weighted Mendelian randomization (BWMR) were utilized to validate the direction. Sensitivity analysis was conducted using the Cochran Q test and MR-Egger intercept test. Additionally, Multivariable MR (MVMR) was employed to examine the independent effect of alcohol intake frequency.Results: In summary, our study identified statistically significant causal associations between four dietary intake and 10 dietary linkings with various spinal disorders through univariable MR, with degenerative spinal changes showing the most significant dietary influence. Alcohol intake was identified as the primary risk factor, with other risk factors including poultry intake and likings for various types of meat. Protective factors mainly included intake and liking of fruits and vegetables. Additionally, various supplementary analytical methods along with heterogeneity and pleiotropy tests have confirmed the robustness of our results. To avoid the interference of diet-related diseases, multivariable MR analysis was conducted, showing that the incidence of cervical disc disorders may be influenced by gout, diabetes, and hypertension.Conclusion: This study indicates a potential causal relationship between dietary factors and the risk of spinal disorders, providing insights for the early detection and prevention. However, the specific pathogenic mechanisms require detailed basic and clinical research in the future.